At CES® 2025, L’Oréal Groupe introduced the L’Oréal Cell BioPrint, a cutting-edge tabletop device that provides personalized skin analysis in just five minutes. The device uses advanced proteomics, the study of protein composition in the human body, to offer detailed insights into skin aging and help users make more informed skincare decisions.
Made possible by L’Oréal’s Longevity Integrative Science™, this groundbreaking technology reveals how biological mechanisms affect skin appearance. The L’Oréal Cell BioPrint was developed in collaboration with NanoEnTek, a Korean startup specializing in microfluidic technology. It provides users with a comprehensive skin assessment, including:
- Skin’s Biological Age: L’Oréal Cell BioPrint calculates the biological age of the skin and offers personalized advice on slowing the visible signs of aging.
- Ingredient Responsiveness: The device helps predict how specific active ingredients, such as retinol, will interact with the skin, reducing guesswork in product selection.
- Proactive Skincare: It helps predict potential skin concerns like dark spots or enlarged pores before they become visible, enabling proactive skincare routines.
Barbara Lavernos, Deputy CEO in charge of Research, Innovation, and Technology at L’Oréal, stated, “At L’Oréal, we continue to innovate by blending cutting-edge discoveries with our expertise in beauty. We are excited to introduce Cell BioPrint, a unique lab-on-a-chip technology that allows users to understand deeper skin insights and proactively enhance the longevity and beauty of their skin.”
A Step Forward in Personalized Skincare
The global skincare market, projected to reach $125 billion by 2024, is increasingly driven by consumer demand for personalized, effective skincare products. A recent survey revealed that nearly 80% of skincare users rely on trial and error to find suitable products, trying an average of seven different cleansers before discovering one that works.
Advanced Science and Technology Behind L’Oréal Cell BioPrint
L’Oréal’s Advanced Research team has built on decades of innovation to identify unique skin biomarkers linked to healthy, youthful skin. The L’Oréal Cell BioPrint device incorporates NanoEnTek’s microfluidic lab-on-a-chip technology, which is based on over 100 patents, to analyze L’Oréal’s groundbreaking protein biomarkers within just five minutes.
The simple, non-invasive process includes:
- Applying a facial tape strip to the cheek and placing it in a buffer solution.
- Loading the solution into the Cell BioPrint cartridge for analysis.
- As the device processes the sample, users complete a short questionnaire about their skin concerns and aging, while the Skin Connect device captures facial images.
Scheduled for a pilot launch with a L’Oréal brand in Asia later in 2025, the L’Oréal Cell BioPrint aims to make personalized skin assessments and customized skincare solutions accessible to a wider audience.
